Top Markets
Coin of the day
Caladrius Biosciences, Inc. Caladrius Biosciences, Inc.

Caladrius Biosciences, Inc.

CLBS
Rang în acțiuni #33297
Caladrius Biosciences, Inc. operates as a clinical-stage biopharmaceutical... Caladrius Biosciences, Inc. operates as a clinical-stage biopharmaceutical company primarily engaged in the development and commercialization of cellular therapies. These therapies aim to either reverse various diseases or stimulate the regeneration of compromised tissue. The company's pipeline includes several key investigational therapies: HONEDRA, which has received the prestigious SAKIGAKE designation, is undergoing Phase II clinical trials as a potential treatment for critical limb ischemia; XOWNA is currently in Phase IIb trials targeting coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy, is being evaluated for chronic kidney disease in patients prior to requiring dialysis. Previously known as NeoStem, Inc., the firm adopted its current name, Caladrius Biosciences, Inc., in June 2015. Established in 1980, the company maintains its corporate headquarters in Basking Ridge, New Jersey.
Preț acțiune
$0.4264
Ultima sincronizare: 2022-09-14
Capitalizare de piață
$7.93M
Schimbare (1 zi)
-16.44%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează Caladrius Biosciences, Inc. (CLBS)

Categorie

Istoric al prețului acțiunii pentru Caladrius Biosciences, Inc. (CLBS)
Cel mai mare preț de închidere: $0.50 pe 2022-09-01

Cel mai mic preț de închidere: $20.36 pe 2015-06-01
Istoric al prețului acțiunii pentru Caladrius Biosciences, Inc. din 2015 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2022 -43.51%
2021 -42.36%
2020 -36.52%
2019 -44.38%
2018 26.20%
2017 2.72%
2016 -70.04%
2015 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$505.24 28.63%
US
$846.09 29.41%
NL
$735.86 7.08%
CH
$1.07K -6.40%
KR
$255.26 13.28%
BE